Pediatric rheumatology

Superb microvascular imaging versus CT angiography for assessing disease activity in pediatric Takayasu arteritis: a comparative study with high consistency

Pediatr Rheumatol Online JPublished Diagnostic accuracy study

Authors' conclusion

SMI and CTA demonstrate comparable diagnostic performance and high consistency in assessing disease activity in pediatric TA.

Study context

Population
Children with TAK treated at one hospital, May 2019–January 2025; active and inactive by National Institutes of Health (NIH) criteria26 active, 21 inactive · active 26 · inactive 21
Participants
47 children
Comparison
Superb microvascular imaging (SMI) vs CT angiography (CTA) for assessing disease activity in pediatric TAK, against NIH criteria
Outcome
Sensitivity, specificity, accuracy and AUC of SMI grading and CTA for diagnosing TAK activity (reference: NIH criteria)
Methodological detailscomparative, single-centre
  • Comparative
  • Single-centre

Performance

As reported in the abstract

Diagnostic performance for TAK activity
Test or modelAUCSensitivitySpecificityAccuracyKappa vs NIH criteria
SMI0.88584.62%95.24%89.36%0.788
CTA0.89588.46%90.48%89.36%0.786

AUC

SMI0.885
CTA0.895

Sensitivity

SMI84.62%
CTA88.46%

Specificity

SMI95.24%
CTA90.48%

Accuracy

SMI89.36%
CTA89.36%

Kappa vs NIH criteria

SMI0.788
CTA0.786

Further findings

SMI grading, active vs inactive

SMI grading significantly higher in the active group than in the inactive group (Z = 5.388, p < 0.001)

Inter-observer agreement for SMI grading

Kappa
0.865 (95% CI: 0.777-0.953)
Complete concordance, 43 of 47 cases
91.49%

Original publication

Superb microvascular imaging versus CT angiography for assessing disease activity in pediatric Takayasu arteritis: a comparative study with high consistency. Pediatr Rheumatol Online J. Published 29 July 2026. doi:10.1186/s12969-026-01255-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.